Eric Bednarski Ph.D Overview
- Firm
- MVM Partners
- Primary Position
-
Partner
- Primary Industry
-
Healthcare
- Active Board Seats
-
3
- Med. Deal Size
-
- Med. Valuation
-
Eric Bednarski Ph.D General Information
Biography
Dr. Eric Bednarski serves as a Partner at MVM Partners. He serves as Board Member at VERO Biotech. He serves as Board Member at OptiNose. He serves as Board Member at Neurolens. Dr. Bednarski served as Board Member and Director at Biotheranostics. Before joining MVM, he was a Partner at Advent Healthcare Ventures and a Principal at Advent International Corporation. Prior to Advent, he was a Director in the Corporate Finance Group of Silicon Valley Bank. He has a B.S. degree in Neural Science from Brown University and a Ph.D. in Biological Sciences from the University of California, Irvine. He is a member of the boards of AccuVein, Inc., bioTheranostics, Inc., Solx, Inc. and Tarsa Therapeutics, Inc. He was previously a director of Heptares Ltd (acquired by Sosei Group Corporation) and was MVM's representative for its investment in Aegerion (NASDAQ: AEGR). He also served as Board Member at AccuVein.
Contact Information
Address
- Old City Hall
- 45 School Street
- Boston, MA 02108
- United States
Eric Bednarski Ph.D Positions (1)
| Firm name | Firm type | Title | Location | Industry | Since |
|---|---|---|---|---|---|
| MVM Partners | Investor | Partner | Boston, MA | Growth/Expansion |
Eric Bednarski Ph.D Board Seats (3)
| Company | Industry | Ownership Status | Financing Status | Location | Since |
|---|---|---|---|---|---|
| MDxHealth | Laboratory Services (Healthcare) | Publicly Held | Formerly VC-backed | Liège, Belgium | |
| Neurolens | Diagnostic Equipment | Privately Held (backing) | Private Equity-Backed | Coppell, TX | |
| VERO Biotech | Other Devices and Supplies | Privately Held (backing) | Private Equity-Backed | Atlanta, GA |
Eric Bednarski Ph.D Lead Partner on Deals (14)
Eric Bednarski Ph.D has been the lead partner on 14 deals. Their latest deal was with Neurolens, a diagnostic equipment company. The deal was made for on 01-Sep-2022.
| Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
|---|---|---|---|---|---|---|
| Neurolens | 01-Sep-2022 | Later Stage VC (Series E) | Completed | Diagnostic Equipment | Coppell, TX | |
| VERO Biotech | 15-Dec-2021 | Completed | Other Devices and Supplies | Atlanta, GA | ||
| OptiNose | 18-Nov-2021 | Completed | Drug Delivery | Yardley, PA | ||
| MDxHealth | 21-Jan-2021 | Completed | Laboratory Services (Healthcare) | Liège, Belgium | ||
| Biotheranostics | 21-Jan-2016 | Completed | Laboratory Services (Healthcare) | San Diego, CA | ||
| Tarsa Therapeutics | 29-May-2014 | Completed | Drug Discovery | Philadelphia, PA | ||
| Tarsa Therapeutics | 16-Mar-2012 | Completed | Drug Discovery | Philadelphia, PA | ||
| AccuVein | 28-Jul-2011 | Completed | Diagnostic Equipment | Medford, NY | ||
| Prexa Pharmaceuticals | 11-May-2011 | Early Stage VC (Series B) | Completed | Pharmaceuticals | Boston, MA | |
| Tarsa Therapeutics | 21-Apr-2011 | Early Stage VC (Series A) | Completed | Drug Discovery | Philadelphia, PA |
Eric Bednarski Ph.D Network (290)
Board Members (89)
| Name | Company | Representing | Location | From |
|---|---|---|---|---|
| Kresimir Letinic Ph.D | Solx (Diagnostic Equipment) | Easton Capital Investment Group | Waltham, MA | |
| Daniel Salazar Ph.D | VERO Biotech | Brace Pharma Capital | Atlanta, GA | |
| Neurolens | Bluestem Capital Company | Coppell, TX | ||
| AccuVein | Self | Medford, NY | ||
| AccuVein | Bessemer Venture Partners | Medford, NY |
Portfolio Executives (149)
| Name | Company | Role | Deal date | Location |
|---|---|---|---|---|
| Danny Perales | Neurolens | Chief Operating Officer & Chief Financial Officer | 01-Sep-2022 | Coppell, TX |
| Thomas Chirillo | Neurolens | Chief Commercial Officer | 01-Sep-2022 | Coppell, TX |
| Neurolens | Chief Revenue Officer | 01-Sep-2022 | Coppell, TX | |
| Neurolens | Chief Technology Officer | 01-Sep-2022 | Coppell, TX | |
| Neurolens | Chief Marketing Officer | 01-Sep-2022 | Coppell, TX |
Fund Team Members (52)
| Name | Investor | Fund | Fund Location |
|---|---|---|---|
| William Kussell | Advent International | Advent Global Private Equity VI | Boston, MA |
| Christopher Pike | Advent International | Advent Health Care & Life Sciences III | Boston, MA |
| Advent International | Boston, MA | ||
| Advent International | Boston, MA | ||
| Advent International | Boston, MA |
Eric Bednarski Ph.D Affiliated Funds (6)
| Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
|---|---|---|---|---|---|---|---|---|
| MVM Fund III | MVM Partners | Growth/Expansion | Fully Invested | 2007 | ||||
| MVM IV | MVM Partners | Growth/Expansion | Closed | 2016 | ||||
| MVM International Life Sciences Fund II | MVM Partners | Venture Capital - Early Stage | Liquidated | 2001 | ||||
| Advent Global Private Equity VI | Advent International | Buyout | Closed | 2008 | ||||
| Advent Health Care & Life Sciences III | Advent International | Venture - General | Closed | 2004 |
Eric Bednarski Ph.D FAQs
-
Who is Eric Bednarski Ph.D?
Dr. Eric Bednarski serves as a Partner at MVM Partners.
-
How much does Eric Bednarski Ph.D typically invest?
Eric Bednarski Ph.D's median deal size is .
-
What is Eric Bednarski Ph.D’s main position?
Eric Bednarski Ph.D’s primary position is Partner.
-
What are the contact details for Eric Bednarski Ph.D?
Eric Bednarski Ph.D’s email address is eb and his phone number is +1 (617) .
-
How many active board seats does Eric Bednarski Ph.D hold?
Eric Bednarski Ph.D holds 3 board seats including MDxHealth, Neurolens, and VERO Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
